Individuals considered at high risk for hypoglycemia are those with 1 or more major risk factor or who have multiple other risk factors
In December last year, Novo reduced the price of Wegovy by 37% from its launch price in India, before its patent expired, Reuters reported
The JAMA real-world study comparing semaglutide and tirzepatide outcomes in clinical practice found that tirzepatide was associated with significantly greater weight loss than semaglutide, confirming that the clinical trial advantage holds outside of controlled environments
A total of 154 individuals were screened, 108 were randomized (54 to each group)
Weight loss from semaglutide often leads to changes in how people feel about their bodies
Managing diarrhea for a successful semaglutide journey Semaglutide-induced diarrhea is a well-documented, dose-dependent side effect caused by the medication's complex effects on digestive system coordination